NAD+ and precursors FAQ: common questions answered
NAD+ helps cells use energy; wellness injection benefits remain unproven.
Also called: NAD+, NAD, nicotinamide adenine dinucleotide, coenzyme I, DPN, NR, nicotinamide riboside, NMN, β-NMN, nicotinamide mononucleotide.
NAD+ and precursors · NAD+ coenzyme and vitamin B3-derived precursors.
- Is NAD+ and precursors FDA-approved? No FDA-approved systemic NAD+, NR or NMN medicine found. Oral NR is a supplement; FDA reversed NMN drug-exclusion in September 2025. Injectable rules are separate.
- How do people take it? Under the skin, three times weekly. Source: reported by users, not an established dose.
- What's the difference between NAD+ and precursors and SS-31 (elamipretide)? NAD+ and precursors: nAD+ helps cells use energy; wellness injection benefits remain unproven. SS-31 (elamipretide): a peptide approved for Barth syndrome muscle strength; benefit needs confirmation and broader energy benefits remain unproven. Why people pair them: a forum plan pairs it with NAD+ for mitochondrial energy; this combination has no established clinical benefit.
- Can I take it with SS-31 / elamipretide? A forum plan pairs it with NAD+ for mitochondrial energy; this combination has no established clinical benefit. The cited post proposed a plan; use and benefit were not independently verified. Source: reported by users. Ask a doctor before combining anything.
- Is it banned in sport? It is unclear (WADA 2026). NAD+, NR and NMN are not named. IV >100 mL per 12 hours is prohibited except specified medical settings; exact product/S0 status needs checking. M2.2 separately addresses total IV infusions or injections over 100 mL per 12 hours, except legitimate hospital treatment, surgical procedures or clinical diagnostic investigations.
- How long does a mixed vial last? No universal post-mixing stability or beyond-use time was verified. Refrigeration does not make a contaminated vial safe.
Related to NAD+ and precursors
- MOTS-c: A peptide the body makes; injection benefits and safety remain unproven.
- SS-31 (elamipretide): A peptide approved for Barth syndrome muscle strength; benefit needs confirmation and broader energy benefits remain unproven.
Sources
- GenoGenix LLC - 718739 - 01/20/2026, FDA · FDA · 2026
- Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC., Turck et al. · EFSA journal. European Food Safety Authority · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- 503A Categories Update for September 2024, FDA · FDA · 2025
- DailyMed - NALTREXONE HYDROCHLORIDE tablet, film coated, DailyMed · 2023
- Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC., Turck et al. · EFSA journal. European Food Safety Authority · 2019
- FDA reminds compounders to use ingredients suitable for sterile compounding, FDA
- FDA to Compounders: Know Your Bulks and Excipients Suppliers, FDA
- Item: /regulated-product-applications/id/application/RP-2116, Food Standards Agency
- Nicotinamide riboside chloride, Food Standards Agency
- NMN 500 (531006), Therapeutic Goods Administration
- Product information, Health Canada
- Re: Docket Number FDA-2023-P-0872, FDA
- Submitted 75-Day Premarket Notifications for New Dietary Ingredients, FDA
- TUE Physician Guidelines: Intravenous infusions and/or injections, World Anti-Doping Agency
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.